Trials / Conditions / Uncomplicated Plasmodium Falciparum Malaria

Uncomplicated Plasmodium Falciparum Malaria

13 registered clinical trials studyying Uncomplicated Plasmodium Falciparum Malaria — 3 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	A Study to Find Out if a Combination of 3 Medicines for the Treatment of Malaria Works as Well and is as Safe NCT05951595	University of Oxford	Phase 3
Completed	Efficacy, Safety and Tolerability of KLU156 in Adults and Children With Uncomplicated P. Falciparum Malaria NCT05842954	Novartis Pharmaceuticals	Phase 3
Completed	Platform Study to Evaluate the Efficacy and Safety of Anti-malarial Agents in Participants With Uncomplicated NCT07235020	Novartis Pharmaceuticals	Phase 2
Recruiting	Platform Study to Evaluate the Efficacy and Safety of Anti-malarial Agents in Patients With Uncomplicated Plas NCT05750628	Novartis Pharmaceuticals	Phase 2
Completed	Platform Study to Evaluate the Efficacy and Safety of Anti-malarial Agents in Participants With Uncomplicated NCT07235033	Novartis Pharmaceuticals	Phase 2
Completed	Test Efficacy Study on the Recommended Antimalarial Drugs in the Democratic Republic of the Congo NCT06076213	Ministry of Public Health, Democratic Republic of the Congo	Phase 4
Recruiting	Triple Artemisinin-based Combination Therapy for Delaying Drug Resistance Development - a Randomized Clinical NCT05764746	Muhimbili University of Health and Allied Sciences	Phase 2 / Phase 3
Completed	Efficacy, Safety and Tolerability of KAF156 in Combination With Lumefantrine Solid Dispersion Formulation (LUM NCT04546633	Novartis Pharmaceuticals	Phase 2
Completed	Extended Duration Artemether-lumefantrine Treatment for Malaria in Children NCT03453840	University of California, San Francisco	Phase 4
Completed	Phase II Efficacy Study of Artefenomel & Piperaquine in Adults & Children With P. Falciparum Malaria. NCT02083380	Medicines for Malaria Venture	Phase 2 / Phase 3
Suspended	Antimalarial Drug Resistance With Assessment of Transmission Blocking Activity NCT01849640	David Saunders	N/A
Completed	Pyronaridine and Artesunate (3:1) in Children With Acute Uncomplicated Plasmodium Falciparum Malaria NCT00331136	Medicines for Malaria Venture	Phase 2
Completed	Rapid Diagnostic Testing and Artemisinin-Based Combination Therapy for Uncomplicated Malaria by Community Heal NCT00301015	Karolinska University Hospital	Phase 4